Show simple item record

Scintigraphic detection of regional disruption of adrenergic neurons in the heart

dc.contributor.authorSisson, James C.en_US
dc.contributor.authorLynch, Joseph J.en_US
dc.contributor.authorJohnson, Jon W.en_US
dc.contributor.authorJaques, Jr. , Sandforden_US
dc.contributor.authorWu, Dorothyen_US
dc.contributor.authorBolgos, Gerald R.en_US
dc.contributor.authorLucchesi, Benedict Roberten_US
dc.contributor.authorWieland, Donald M.en_US
dc.date.accessioned2006-04-07T20:27:33Z
dc.date.available2006-04-07T20:27:33Z
dc.date.issued1988-07en_US
dc.identifier.citationSisson, James C., Lynch, Joseph J., Johnson, Jon, Jaques, Jr., Sandford, Wu, Dorothy, Bolgos, Gerald, Lucchesi, Benedict R., Wieland, Donald M. (1988/07)."Scintigraphic detection of regional disruption of adrenergic neurons in the heart." American Heart Journal 116(1, Part 1): 67-76. <http://hdl.handle.net/2027.42/27464>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6W9H-4CN4MM5-1BK/2/6796bbaad70074b32763ce62d559b1dden_US
dc.identifier.urihttps://hdl.handle.net/2027.42/27464
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3394634&dopt=citationen_US
dc.description.abstractExperiments were designed to detect regional disruptions of adrenergic neurons in the hearts of living dogs. The neuron disruption was achieved by the application of phenol to the epicardium of the left ventricle. Evidence for denervation was the reduction in endogenous norepinephrine (NE) concentrations in the myocardium beneath the region of phenol treatment and toward the apex. Radiolabeled meta-iodobenzylguanidine (MIBG) acts as an analog of NE and as such is concentrated in adrenergic nerve terminals. Following phenol application, MIBG labeled with 125I was found, 20 hours after injection, to be distributed within myocardium in patterns comparable to those of NE. However, left stellectomy did not alter the distributions of NE or 125I-MIBG in the myocardium and apparently did not disrupt adrenergic innervation. MIBG labeled with 123I enabled scintigraphic images of heart neurons in the living dog 3 and 20 hours after injection; these images portrayed the regions of adrenergic neuron disruption caused by phenol treatment. Concentrations of thallium-201 depicted on scintigraphic image and of triphenyltetrazolium observed on in vitro staining demonstrated no myocardial injury. Thus scintigraphy with 123I-MIBG will display regional adrenergic denervations in the heart.en_US
dc.format.extent5147362 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleScintigraphic detection of regional disruption of adrenergic neurons in the hearten_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan Medical Center, Department of Internal Medicine (Nuclear Medicine), Ann Arbor, Mich., USA; University of Michigan Medical Center, Department of Pharmacology, Ann Arbor, Mich., USA.en_US
dc.contributor.affiliationumUniversity of Michigan Medical Center, Department of Pharmacology, Ann Arbor, Mich., USA; University of Michigan Medical Center, Department of Internal Medicine (Nuclear Medicine), Ann Arbor, Mich., USA.en_US
dc.contributor.affiliationumUniversity of Michigan Medical Center, Department of Pharmacology, Ann Arbor, Mich., USA; University of Michigan Medical Center, Department of Internal Medicine (Nuclear Medicine), Ann Arbor, Mich., USA.en_US
dc.contributor.affiliationumUniversity of Michigan Medical Center, Department of Pharmacology, Ann Arbor, Mich., USA; University of Michigan Medical Center, Department of Internal Medicine (Nuclear Medicine), Ann Arbor, Mich., USA.en_US
dc.contributor.affiliationumUniversity of Michigan Medical Center, Department of Pharmacology, Ann Arbor, Mich., USA; University of Michigan Medical Center, Department of Internal Medicine (Nuclear Medicine), Ann Arbor, Mich., USA.en_US
dc.contributor.affiliationumUniversity of Michigan Medical Center, Department of Pharmacology, Ann Arbor, Mich., USA; University of Michigan Medical Center, Department of Internal Medicine (Nuclear Medicine), Ann Arbor, Mich., USA.en_US
dc.contributor.affiliationumUniversity of Michigan Medical Center, Department of Pharmacology, Ann Arbor, Mich., USA; University of Michigan Medical Center, Department of Internal Medicine (Nuclear Medicine), Ann Arbor, Mich., USA.en_US
dc.contributor.affiliationumUniversity of Michigan Medical Center, Department of Pharmacology, Ann Arbor, Mich., USA; University of Michigan Medical Center, Department of Internal Medicine (Nuclear Medicine), Ann Arbor, Mich., USA.en_US
dc.identifier.pmid3394634en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/27464/1/0000505.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0002-8703(88)90251-7en_US
dc.identifier.sourceAmerican Heart Journalen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.